An implantable lead includes a lead body extending along a central axis and having a central lumen. The implantable lead includes a drive coupling rotatably mounted in the central lumen. The drive coupling includes a drive shaft having an outer shaft surface defining a non-circular shaft profile. The implantable lead includes a helical fixation element mounted on the drive coupling.
A torque transfer tool includes a drive stylet and a lead-stylet locking tool. The drive stylet includes a stylet body extending along a longitudinal axis to a stylet tip, and a projection extending laterally outward from the stylet body. The lead-stylet locking tool includes a tool body having a body wall extending around a central lumen. The central lumen extends along the longitudinal axis from a distal tool end to a proximal tool end. The central lumen includes a connector body subsegment sized to receive a connector body of an implantable lead. The central lumen includes a pin subsegment sized to receive a connector pin of the implantable lead. A lateral space extends through the body wall from the central lumen to receive the projection of the drive stylet.
An electroanatomical mapping system tracks and visualizes an item of interest, such as a medical device or anatomical structure, as the item moves within a non-ionizing localization field. The system localizes the item within the localization field and determines the initial position of the item with respect to an imaging device (e.g., an intracardiac echocardiography catheter) field of view. The system displays a region of the field of view containing the initial position of the item if it is within the field of view. If not, the system can output a notification. As the item moves, the system can update the displayed region so that it remains focused on the item, and can output a notification if the item exits the field of view. The displayed region(s) can include one or more two-dimensional image slices, optionally output as a three-dimensional volumetric image.
A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
A61B 34/00 - Chirurgie assistée par ordinateurManipulateurs ou robots spécialement adaptés à l’utilisation en chirurgie
4.
LEVERAGING CONTINUOUS GLUCOSE, KETONE, LACTATE MONITORING DATA AND DIETARY INFORMATION FROM FOOD APPLICATIONS TO INFORM GLP-1 RA THERAPY
A service treats a user by recommending individualized insulin dose reductions prior to initiation of a therapy involving using a glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment, where the GLP-1 RA treatment is designed to treat a physiological condition of the user, and where a wearable monitor measures a physiological level of the user. The measured physiological level is used to facilitate the GLP-1 RA treatment.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
5.
METHODS, DEVICES AND SYSTEM FOR PROVIDING DIABETIC CONDITION DIAGNOSIS AND THERAPY
Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
6.
SINGLE USE SAFETY CAP FOR USE WITH NEEDLELESS CONNECTORS
A safety cap for use with a needleless connector. The safety cap includes a body configured to at least partially enclose a head of the needleless connector (NC). The body is configured to achieve a first configuration that can be securely sealed to the NC and a second configuration that cannot be securely sealed to the NC. The second configuration is different from the first configuration. The safety cap also includes a detent in communication with the body which is configured to prevent the body from transitioning from the second configuration back to the first configuration.
A computer implemented method and system for detecting an arrhythmia are provided. The method is under control of one or more processors configured with executable instructions. The method obtains far field cardiac activity (CA) signals sensed at electrodes located remote from a heart over a period of time and applies a feature attenuation filter to the CA signals to form modified CA signals. The feature attenuation filter reduces potential T-waves as a feature not of interest. The method calculates a duty cycle (DC) characteristic of the modified CA signals with respect to duty cycle boundaries and detects an arrhythmia based on the DC characteristic.
A method of loading a prosthetic heart valve into a delivery device may include advancing the prosthesis through a tapered compression member until a valve retainer protrudes from the compression member. Then, a tip of the delivery device may be advanced through the prosthesis until a retaining element of the delivery device is positioned adjacent to the retainer. The retainer may be positioned within a recess in the retaining element. A locking ring may be advanced from a first position on the delivery device to a second position in which the locking ring overlies either (i) the retainer or (ii) a portion of the stent adjacent to the first retainer, so that the locking ring locks the first retainer within the first recess. A distal sheath of the delivery device may be moved to cover the prosthesis.
A delivery device for a collapsible prosthetic heart valve includes a handle having proximal and distal portions coupled together so that the proximal portion is rotatable relative to the distal portion, while the proximal portion is translationally fixed relative to the distal portion. Inner and outer catheter shafts are each operably coupled to the handle and each extend distally from the handle. A distal sheath extends from the outer catheter shaft and is disposed about the inner catheter shaft to form a compartment sized to receive the prosthetic heart valve. The inner catheter shaft and the distal sheath are movable relative to one another to cover or uncover the compartment. Rotation of the proximal portion of the handle, while the distal portion of the handle remains stationary, causes rotation of both the inner catheter shaft and the outer catheter shaft.
Systems and methods for monitoring return patch impedances are provided. A tissue therapy system includes a catheter comprising at least one electrode, the catheter implantable in a patient, a first return patch electrode configured to be applied to skin of the patient, a second return patch electrode configured to be applied to the skin of the patient, and an impedance measuring circuit electrically coupled to the at least one catheter electrode, the first return patch electrode, and the second return patch electrode. The impedance measuring circuit is configured to drive currents between the at least one catheter electrode, the first return patch electrode, and the second return patch electrode, detect, using a voltage at the at least one catheter electrode as a reference voltage, voltages generated in response to the driven currents, and measure impedances based on the driven currents and the detected voltages.
A61B 18/12 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci par chauffage en faisant passer des courants à travers les tissus à chauffer, p. ex. des courants à haute fréquence
A61B 18/16 - Électrodes neutres ou passives pour mise à la terre
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
Methods and apparatus to reduce anxiety using mixed reality are disclosed herein. An example method of reducing anxiety in a person during a blood collection process includes providing a mixed reality headset to a person prior to collecting blood from the person. The method includes initiating a mixed reality program on the mixed reality headset. The mixed reality program causes a display device to display a mixed reality environment with one or more virtual objects on glasses of the headset, determines a gaze direction of the eyes of the person, and causes a change in one or more of the virtual objects in the mixed reality environment based on the gaze direction. The method further includes collecting blood from the person while the person is exposed to the mixed reality program.
G06T 7/70 - Détermination de la position ou de l'orientation des objets ou des caméras
G06T 13/40 - Animation tridimensionnelle [3D] de personnages, p. ex. d’êtres humains, d’animaux ou d’êtres virtuels
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
13.
MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USE
A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61M 5/315 - PistonsTiges de pistonGuidage, blocage, ou limitation des mouvements de la tigeAccessoires disposés sur la tige pour faciliter le dosage
G01N 33/487 - Analyse physique de matériau biologique de matériau biologique liquide
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16Z 99/00 - Matière non prévue dans les autres groupes principaux de la présente sous-classe
A biostimulator, such as a leadless cardiac pacemaker, has a header assembly that includes an antenna. A header assembly includes an antenna cap having an antenna loop embedded in a cap body. The cap body includes a dielectric material, and the antenna loop extends about a central channel of the cap body. The central channel extends along a longitudinal axis over a cap length, and the cap body has a cap width transverse to the longitudinal axis. The cap body has an aspect ratio of the cap width to the cap length greater than 1. A header assembly includes an antenna loop of the antenna encased in a header body of the header assembly. The header assembly includes a fixation element. A proximal end of the fixation element is encased in the header body. Other embodiments are also described and claimed.
A prosthetic heart valve may include a balloon-expandable frame formed of a plastically-expandable material, and a self-expanding frame formed of a self-expanding material, the self-expanding frame including a plurality of commissure attachment features. The valve may include a plurality of prosthetic leaflets, wherein pairs of adjacent prosthetic leaflets form commissures, each of the commissures being coupled to a corresponding one of the plurality of commissure attachment features. The balloon-expandable frame may be coupled to the self-expanding frame to form a hybrid frame, the hybrid frame including an inflow end and an outflow end, the balloon-expandable frame being positioned at the inflow end of the hybrid frame, and the self-expanding frame being positioned at the outflow end of the hybrid frame.
A prosthetic heart valve implantation system, including a collapsible and expandable prosthetic heart valve, a delivery system for delivering and deploying the collapsible and expandable prosthetic heart valve, and an anchoring system operably coupled to the delivery system. The delivery system includes a delivery catheter and an inflatable balloon at a distal end portion of the delivery catheter. The anchoring system includes an anchor having a compressed or stowed condition, and an expanded or deployed condition, the anchor being configured engage with patient anatomy in the expanded or deployed configuration of the anchor to anchor the delivery system relative to patient anatomy to restrict axial movement of the delivery catheter during inflation of the inflatable balloon.
In some examples, an occluder delivery system includes a delivery cable including a hollow helical strand having a first outer diameter and a heat shrink, and a rigid rod having a second outer diameter, the rigid rod being coupled to a proximal end of the hollow helical strand, the first outer diameter and the second outer diameter being equal.
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
18.
INTERVENTIONAL SYSTEM HAVING COOPERATIVE BALLOON CATHETER AND GUIDEWIRE
An interventional system is used to treat a lesion in a target anatomy. The interventional system includes a balloon catheter and a guidewire. The balloon catheter includes a balloon coupled to a catheter shaft. The catheter shaft includes a guidewire lumen having a lumen diameter. The guidewire includes a coil tip coupled to a guidewire shaft at a proximal joint. A coil diameter of the coil tip at the proximal joint is larger than the lumen diameter of the catheter shaft. The interventional system can be used to access and treat the lesion in the target anatomy. Other embodiments are also described and claimed.
Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
Systems, devices, and methods for power management and/or for synchronous advertising-based communication in an analyte monitoring environment are set forth. Information pertaining to clock accuracy is exchanged between a receiver device and an on-body device. The system is configured to make power management decisions based on the clock accuracy information. Avoidance of extended listening windows can provide power savings through prevention or minimization of communication with receiver devices having relatively low clock accuracies. Wireless transmission and reception between devices in an analyte monitoring system in accordance with a synchronous advertising-based protocol are set forth. Advertisements are made by an on-body device and responses are transmitted back from receiver devices. The protocol is highly adaptable for power management. Supplementary information request techniques using synchronous advertising-based protocols and/or secondary channels are set forth. Many variations are set forth.
A service treats a user by recommending individualized insulin dose reductions prior to initiation of a therapy involving using a glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment, where the GLP-1 RA treatment is designed to treat a physiological condition of the user, and where a wearable monitor measures a physiological level of the user. The measured physiological level is used to facilitate the GLP-1 RA treatment.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
The disclosed principles provide for single use caps that may be applied to any of a number of receptacles, containers, vessels, needless connectors, or other device. A single use cap as disclosed herein includes a component that, when the cap is threaded onto a receptacle or device, is moved from an “unused” to a “used” position by the twisting force applied to the cap when secured onto the receptacle or device. Specifically, once the threads of the receptacle or device are received into the cap and a twisting or tightening force is continued to be applied to the cap, the continued twisting force causes this component to rotate laterally so that once the cap is removed from the receptacle or device, the threads of the cap are no longer reachable by the threads on the receptacle or device.
B65D 55/08 - Éléments annulaires encerclant les cols des réceptacles
B65D 1/02 - Bouteilles ou réceptacles similaires, à cols ou à ouvertures rétrécies analogues, conçus pour verser le contenu
B65D 39/10 - Éléments de fermeture filetés ou analogues fixés par rotationDouilles à cet effet avec came à baïonnette
B65D 41/06 - Capuchons ou couvercles en forme de capuchons filetés ou similaires, fixés par rotation avec came à baïonnette
B65D 45/32 - Dispositifs de serrage ou autres dispositifs presseurs pour fixer ou retenir les éléments de fermeture exerçant une pression radiale, p. ex. bandes contractables encerclant l'élément de fermeture
23.
METHOD AND DEVICE FOR MANAGING PROCESSING ACTIVITY PATTERNS
Methods, devices and program products are provided and include memory to store a baseline task handling (TH) pattern and TH circuitry including one or more processors. The TH circuitry is configured to perform tasks associated with one or more of collecting one or more CA signals or environmental event signals. The TH circuitry analyzes the one or more CA signals or environmental event signals, delivers therapy, detects communications requests, or maintains communications sessions with an external device. The IMD monitors a TH characteristic in connection with the performing the tasks, compares the TH characteristic to the baseline TH pattern and implements a corrective action in response to the compare of the TH characteristic and the baseline TH pattern.
Aspects of the present disclosure are directed to, for example, a high-thermal-sensitivity ablation catheter tip including a thermally-insulative ablation tip insert supporting at least one temperature sensor electrically coupled to a flexible electronic circuit and encapsulated, or essentially encapsulated, by a conductive shell. Also disclosed is a method of controlling the temperature of an ablation catheter tip while creating a desired lesion using various forms of energy and energy delivery.
A61B 5/364 - Détection d'intervalle ECG anormal, p. ex. des extrasystoles ou des battements cardiaques ectopiques
A61B 8/12 - Diagnostic utilisant des ondes ultrasonores, sonores ou infrasonores dans des cavités ou des conduits du corps, p. ex. en utilisant des cathéters
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
A61B 18/18 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci par application de radiations électromagnétiques, p. ex. de micro-ondes
A61B 18/24 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci par application de radiations électromagnétiques, p. ex. de micro-ondes en utilisant des lasers le faisceau étant dirigé le long, ou à l'intérieur d'un conduit flexible, p. ex. d'une fibre optiquePièces à main à cet effet avec un cathéter
In some examples, an occluder delivery system includes a delivery cable including a hollow helical strand having a first outer diameter and a heat shrink, and a rigid rod having a second outer diameter, the rigid rod being coupled to a proximal end of the hollow helical strand, the first outer diameter and the second outer diameter being equal.
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
A medical device for treating a target site includes a body extending from a proximal end to a distal end along a central longitudinal axis, the body including a proximal disc adjacent the proximal end, a distal disc adjacent the distal end, and a waist extending between and connecting the proximal and distal discs. The body further includes an inner layer formed from a first braided self-expanding material and an outer layer formed from a second braided self-expanding material, wherein the outer layer surrounds the inner layer and is independent from the inner layer. Each of the proximal disc, the distal disc, and the waist are defined in part by each of the inner layer and the outer layer. The first braided self-expanding material includes a first number of wires and the second braided self-expanding material includes a second number of wires greater than the first number of wires.
Disclosed are methods and compositions, including infant formulas, for promoting a healthy gut and/or a strong intestinal barrier. The compositions include chondroitin, for instance in the form of chondroitin sulfate, and one or more natural forms of choline, including for example glycerophosphocholine (GPC) and/or phosphocholine. It has presently been found that the combination of chondroitin and a natural form of choline synergistically promotes gut health, e.g. by protecting the intestinal barrier against inflammation and/or stimulating repair of the intestinal barrier after inflammation.
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
A61K 31/737 - Polysaccharides sulfatés, p. ex. sulfate de chondroïtine, sulfate de dermatane
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A sealing system for sealing a vessel by a cap is disclosed, and may include a vessel having a main cavity, a vessel locking ridge, and a locking cavity, and a cap having a cap locking ridge and a sealing o-ring. The vessel locking ridge is configured to elastically deflect. The locking cavity may be adjacent to the vessel locking ridge. The cap may be configured to couple to the vessel and to seal the main cavity of the vessel. When the cap is coupled to the vessel, the cap locking ridge may be placed in the locking cavity of the vessel and the sealing o-ring of the cap may be positioned within the cavity of the vessel such that the sealing o-ring creates a seal against an interior wall of the main cavity of the vessel. A capping machine and a method of capping the vessel are also disclosed.
B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
B65B 7/28 - Fermeture de réceptacles ou récipients semi-rigides ou rigides, non déformés par le contenu ou n'en prenant pas la forme, p. ex. boîtes ou cartons en appliquant des fermetures séparées préformées, p. ex. couvercles, capuchons
A facility for verifying the automatic capping of a fluid containment vessel is described. The facility accesses a first image captured of a fluid containment vessel subsequent to being automatically capped. The facility accesses at least one template image cropped from a reference image captured of a second fluid containment vessel verified as having been successfully capped. The facility performs a template matching operation between each template image and the first image to obtain a matching score. The facility accesses one or more empirically-derived matching score thresholds, and compares the obtained matching scores to the accessed thresholds. Based at least in part on a result of the comparison, the facility raises an error indicating that the first fluid containment vessel was unsuccessfully capped.
G06V 10/22 - Prétraitement de l’image par la sélection d’une région spécifique contenant ou référençant une formeLocalisation ou traitement de régions spécifiques visant à guider la détection ou la reconnaissance
G06V 10/24 - Alignement, centrage, détection de l’orientation ou correction de l’image
G06V 10/25 - Détermination d’une région d’intérêt [ROI] ou d’un volume d’intérêt [VOI]
G06V 10/75 - Organisation de procédés de l’appariement, p. ex. comparaisons simultanées ou séquentielles des caractéristiques d’images ou de vidéosApproches-approximative-fine, p. ex. approches multi-échellesAppariement de motifs d’image ou de vidéoMesures de proximité dans les espaces de caractéristiques utilisant l’analyse de contexteSélection des dictionnaires
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p. ex. des objets vidéo
30.
CATHETER ANCHORING TO CONTROL INFLOW PLACEMENT OF BALLOON EXPANDABLE PROSTHETIC HEART VALVE
A prosthetic heart valve implantation system, including a collapsible and expandable prosthetic heart valve, a delivery system for delivering and deploying the collapsible and expandable prosthetic heart valve, and an anchoring system operably coupled to the delivery system. The delivery system includes a delivery catheter and an inflatable balloon at a distal end portion of the delivery catheter. The anchoring system includes an anchor having a compressed or stowed condition, and an expanded or deployed condition, the anchor being configured engage with patient anatomy in the expanded or deployed configuration of the anchor to anchor the delivery system relative to patient anatomy to restrict axial movement of the delivery catheter during inflation of the inflatable balloon.
A medical device communication system with a modular design to communicate with different types of medical devices, such as physiological sensors. The modular design is implemented using an extensible software library that provides a uniform framework for various applications or third party applications access to medical device data. The modular design also allows for regulated and unregulated portions of the system to be integrated into the system while allowing each portion to be updated separately. The regulated portion of the system may include components, such as sensors and the software library, that are subject to regulatory approval while the unregulated portion may include applications that are not subject to regulatory approval. Thus, the system enables a third party application developer to avoid having to submit the application to a regulatory agency for an application making use of the sensor data.
G06F 21/32 - Authentification de l’utilisateur par données biométriques, p. ex. empreintes digitales, balayages de l’iris ou empreintes vocales
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
34.
METHOD AND APPARATUS FOR PROVIDING DATA PROCESSING AND CONTROL IN MEDICAL COMMUNICATION SYSTEM
Methods and apparatus for providing data processing and control for use in a medical communication system are provided. Such methods and apparatus may include determining a glucose value in a bodily fluid based on an estimated glucose temperature related signal and the glucose related signal in the bodily fluid, wherein the glucose temperature related signal may be estimated based on the temperature of the skin or the ambient temperature.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/1495 - Étalonnage ou test des sondes in vivo
G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
35.
SYSTEMS AND METHODS FOR VERGENCE MATCHING WITH AN OPTICAL PROFILE AND USING REFRACTIVE INDEX WRITING
Systems and methods for improving vision of a subject implanted with an intraocular lens (IOL). In some embodiments, a method includes vergence matching for an intraocular lens (IOL) having an optical profile induced by refractive index writing.
A biostimulator, such as a leadless cardiac pacemaker, including a fixation element and an electrode mounted on a resilient scaffold, is described. The fixation element and the resilient scaffold are coupled to a housing of the biostimulator. The resilient scaffold can support the electrode against a target tissue at a location that is radially offset from a location where the fixation element anchors the housing to the target tissue. A flexibility of the resilient scaffold allows the electrode to conform to a shape and movement of the target tissue when the housing is rigidly fixed to the target tissue by the fixation element. The resiliently supported electrode that is radially offset from the anchor point can reliably pace the target tissue without piercing the target tissue. Other embodiments are also described and claimed.
In some examples, a delivery device includes a handle, a catheter sheath defining a lumen and extending distally from the handle, the catheter sheath having a deflectable proximal curve and a deflectable distal curve spaced from the deflectable proximal curve, one or more coextruded stripes disposed at the deflectable distal curve, at least one pull ring formed within the catheter sheath, one or more pull wires coupled to the at least one pull ring, and a first deflection knob for actuating the catheter sheath at the deflectable proximal curve and a second deflection knob for actuating the catheter sheath at the deflectable distal curve.
A medical device includes a device frame, including a proximal portion and a distal portion and configured to selectively transition between a collapsed configuration and an expanded configuration. The medical device also includes at least one cover, wherein at least one cover is coupled to at least one of the proximal and distal portions.
Assemblies for storing and distributing a plurality of sharps include a plurality of layers including a first layer having a first support structure coupled with a first sharp module, and a second layer having a second support structure coupled with a second sharp module. An interleaf layer is located between the first layer and the second layer and has at least one first protrusion extending from a first surface in a first direction and at least one second protrusion extending from a second surface in a second direction. The first protrusion and the second protrusion are configured to prevent tilting movement of the first sharp module and the second sharp module. The at least one first protrusion and the at least one second protrusion may each be a single protrusion that extends a length of the interleaf layer or a plurality of discreet protrusions.
A61M 5/00 - Dispositifs pour faire pénétrer des agents dans le corps par introduction sous-cutanée, intravasculaire ou intramusculaireAccessoires à cet effet, p. ex. dispositifs de remplissage ou de nettoyage, appuis-bras
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
B65D 81/02 - Réceptacles, éléments d'emballage ou paquets pour contenus présentant des problèmes particuliers de stockage ou de transport ou adaptés pour servir à d'autres fins que l'emballage après avoir été vidés de leur contenu spécialement adaptés pour protéger leur contenu des dommages mécaniques
40.
LOADER TUBING FOR LEFT ATRIAL APPENDAGE OCCLUDER DELIVERY SYSTEM
In some examples, a medical device loader includes a cylindrical body extending between a proximal end and a distal end, the cylindrical body having an inner surface defining an inner diameter, an outer surface and a central lumen for accepting a medical device; and one or more axially-extending protrusions disposed on the outer surface of the cylindrical body, the one or more axially-extending protrusions extending radially outward to a greater extent than other portions of the cylindrical body.
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
A61M 25/01 - Introduction, guidage, avance, mise en place ou maintien en position des cathéters
A61M 25/06 - Aiguilles avec un guide pour piquer le corps ou analogues
A61M 39/00 - Tubes, raccords ou accouplements pour tubes, soupapes, voies d'accès ou similaires, spécialement adaptés pour un usage médical
A61M 39/06 - Soupapes hémostatiques, c.-à-d. éléments formant joint autour d'une aiguille, d'un cathéter ou similaire, et se fermant après leur retrait
41.
ANALYTE SENSORS AND SENSING METHODS FOR DETECTING CREATININE
Creatinine levels may be monitored as a measure of kidney function. Conventionally, blood and/or urine tests are used for this purpose. Analyte sensors capable of monitoring creatinine in vivo may comprise: a sensor tail comprising at least a first working electrode, a creatinine-responsive active area disposed upon a surface of the first working electrode, a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, and an oxygen scavenger located upon the sensor tail in proximity to the creatinine-responsive active area. The creatinine-responsive active area comprises a first electron transfer agent, a first polymer, and an enzyme system comprising multiple enzymes, particularly creatinine amidohydrolase, creatine amidinohydrolase, and sarcosine oxidase, that are capable of acting in concert to facilitate detection of creatinine. An oxidase enzyme may serve as the oxygen scavenger, particularly glucose oxidase when detecting creatinine in fluids also containing glucose.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
42.
Atrioventricular Valve Modification Systems, Devices, and Methods
A method of implanting a prosthetic atrioventricular valve into a native atrioventricular valve includes delivering a fixation device to the native valve, and applying the fixation device to engage and approximate free edges of two leaflets of the native valve. After applying the fixation device, the prosthetic valve is delivered to the native valve while the prosthetic valve is in a collapsed condition. The prosthetic valve is then be deployed into the native valve so that the prosthetic valve expands into engagement with the native valve. A transcatheter positioning device for an atrioventricular valve modification device delivery system is also provided. The positioning device comprises a positioning member having an undeployed configuration for delivery of the positioning device to an atrioventricular valve modification device delivery site in the heart of a patient and a deployed configuration for the positioning member to engage and reposition an object in the heart.
An implantable cardioverter-defibrillator (ICD) includes one or more capacitors, a secondary battery and a primary battery. The implantable cardioverter-defibrillator also includes a capacitor charging circuit. A controller operates the capacitor charging circuit such that the one or more capacitors are charged with electrical energy from the secondary battery or the primary battery. In some instances, the controller selects whether the capacitors are charged with electrical energy from the secondary battery or the primary battery. In some instances, the one or more capacitors are charged with electrical energy from the secondary battery and the ICD includes a charging circuit that the controller operates such that electrical energy from the primary battery recharges the secondary battery.
Disclosed herein are systems and assays that employ magnetically susceptible beads and point-of-care devices comprising magnetic immunosensors to determine the amount of glial fibrillary acidic protein (GFAP) in a biological sample obtained from a subject.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
45.
COMPOSITIONS AND METHODS FOR DETECTING ROCAHEPEVIRUS
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
A delivery device includes a handle (100), a catheter sheath (1600) defining a lumen and extending distally from the handle, the catheter sheath having a deflectable proximal curve (C1) and a deflectable distal curve (C2) spaced from the deflectable proximal curve, one or more coextruded stripes (1650) disposed at the deflectable distal curve, two rings (610) formed within the catheter sheath, two pull wires coupled to each one of pull rings, and a first deflection knob (500A) for actuating the catheter sheath at the deflectable proximal curve and a second deflection knob (500B) for actuating the catheter sheath at the deflectable distal curve.
A61M 25/01 - Introduction, guidage, avance, mise en place ou maintien en position des cathéters
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
A61M 39/06 - Soupapes hémostatiques, c.-à-d. éléments formant joint autour d'une aiguille, d'un cathéter ou similaire, et se fermant après leur retrait
47.
Display screen or portion thereof with graphical user interface
Provided herein are methods, and kits for detecting Rocahepevirus (rHEV) species 7 in human subjects. In certain embodiments, provided herein are Rocahepevirus species 7 specific peptides, and methods for detecting Rocahepevirus species 7 antibodies or antigen-binding fragments thereof in human subjects.
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
A tunable fixation device for fixation of heart valve leaflets includes a central assembly, an arm moveably coupled to the central assembly, and a gripping element moveable relative to the arm to capture a native leaflet therebetween. The arm has a body portion and a wire frame coupled to the body portion. The wire frame has a first and second wire segment, and an interconnection portion interconnecting the first and second wire segments. The interconnection portion is slidingly engaged with the body portion. The first wire segment is configured to deform upon force applied to the second wire segment by sliding movement of the interconnection portion relative to the body portion, and the second wire segment is configured to deform upon force applied to the first wire segment by sliding movement of the interconnection portion relative to the body portion.
Intraocular lenses for reducing Negative dysphotopsia (ND) are described herein. An example ophthalmic lens can include an optic with a central optical zone disposed about the optical axis and an attenuation optical zone disposed about the central optical zone, wherein the attenuation optical zone is contiguous with the central optical zone, and wherein optical power of the ophthalmic lens is gradually reduced within the attenuation optical zone.
Embodiments are disclosed of an assembly adapted to be attached to a biostimulator. The assembly includes a flange adapted to be attached to a distal end of the biostimulator. The flange includes a base adapted to be attached to the distal end of the biostimulator, and a hub positioned on the base. The hub has a proximal end, a distal end, an interior surface, and an exterior surface. The proximal end of the hub is attached to the base, and the exterior surface includes a first attachment mechanism. A fixation mount is adapted to be attached to the flange. The fixation mount includes a second attachment mechanism to engage with the first attachment mechanism. An assembly lock engages the first attachment mechanism and the second attachment mechanism to fasten the flange to the fixation mount.
In some examples, a method of manufacturing a prosthetic heart includes providing a stent and a valve assembly, the valve assembly including at least one of an inner cuff and an outer cuff, and a plurality of leaflets, sputter coating a bimetallic layer of a first metal and a second metal different from the first metal onto a surface of at least one component selected from the plurality of leaflets, the inner cuff and the outer cuff, and coupling the valve assembly to the stent.
Methods and analyte sensors including at least a first working electrode having a first active area thereon, and performing a dip coating operation to deposit a bilayer membrane upon the first working electrode and the first active area. The bilayer may include an inner layer having a first membrane polymer and an outer layer having a second membrane polymer, the first membrane polymer and the second membrane polymer differing from one another. The dip coating operation may comprise one or more first dips in a first membrane formulation to form the inner layer of the bilayer membrane and one or more second dips in a second membrane formulation to form the outer layer of the bilayer membrane upon the inner layer.
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
A loading tool for loading a biostimulator onto a biostimulator transport system is described. The loading tool includes a body portion having a biostimulator volume to receive the biostimulator, and a receptacle portion extending from the body portion. The receptacle portion has a receptacle wall extending around a receptacle volume to receive the biostimulator transport system. The receptacle volume is in fluid communication with the biostimulator volume. A loading slot extends laterally through the receptacle wall into the receptacle volume. Other embodiments are also described and claimed.
A pacemaker device including a proximal end portion that includes a housing containing pacing electronics and battery material. The pacemaker device also includes a mount positioned at a distal end portion of the pacemaker device and a pliable assembly for fixating the pacemaker device to a tissue site. The pliable assembly is coupled to a mount and one or more electrodes electrically configured to receive one or more electrical signals from the tissue site and/or deliver one or more pacing signals to the tissue site.
A system for determining a change in position of an implanted medical device (IMD) within an implant pocket is provided. The system includes an accelerometer configured to be implanted in a patient, the accelerometer configured to obtain accelerometer data along at least one axis. The system also includes one or more processors configured to determine the patient is engaging in a determined activity over an activity period, and obtain the accelerometer data during the activity period. The one or more processors are also configured to identify postures of the patient and corresponding posture periods during the activity period based on the accelerometer data, determine a duration related to a non-standing posture identified from the postures identified, and identify a migration of the IMD within the implant pocket based on the duration of the non-standing posture exceeding a duration threshold.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/103 - Dispositifs de mesure pour le contrôle de la forme, du dessin, de la dimension ou du mouvement du corps ou de parties de celui-ci, à des fins de diagnostic
57.
Ventricular Control of Prosthetic Atrioventricular Valve
According to one aspect of the disclosure, a prosthetic heart valve system includes a collapsible and expandable prosthetic atrioventricular valve including an atrial disk, a ventricular disk, a center portion, and a plurality of prosthetic leaflets. The system may include a delivery device that includes a catheter having a valve cover configured to maintain the prosthetic heart valve in a collapsed condition for delivery. The delivery device may include an expansion restriction mechanism and a shaft system including an atrial tube and a ventricular tube. In a delivery condition, the prosthetic heart valve is collapsed within the valve cover and pluralities of sutures may connect the atrial and ventricular tubes to the atrial and ventricular disks, respectively, to restrict and control the expansion of the ends of the prosthetic heart valve.
In some examples, a medical device loader includes a cylindrical body extending between a proximal end and a distal end, the cylindrical body having an inner surface defining an inner diameter, an outer surface and a central lumen for accepting a medical device; and one or more axially-extending protrusions disposed on the outer surface of the cylindrical body, the one or more axially-extending protrusions extending radially outward to a greater extent than other portions of the cylindrical body.
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
Systems, devices, and methods for power management and/or for synchronous advertising-based communication in an analyte monitoring environment are set forth. Information pertaining to clock accuracy is exchanged between a receiver device and an on-body device. The system is configured to make power management decisions based on the clock accuracy information. Avoidance of extended listening windows can provide power savings through prevention or minimization of communication with receiver devices having relatively low clock accuracies. Wireless transmission and reception between devices in an analyte monitoring system in accordance with a synchronous advertising-based protocol are set forth. Advertisements are made by an on-body device and responses are transmitted back from receiver devices. The protocol is highly adaptable for power management. Supplementary information request techniques using synchronous advertising-based protocols and/or secondary channels are set forth. Many variations are set forth.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
An on-body device for monitoring an analyte level of a user has a housing. The housing has a vent inlet and a vent outlet that allow passage of water vapor therethrough. Examples of moisture permeable seals, solid foam seals, and fibrous seals are provided. The housing has a base adapted to permit egress of moisture from regions adjacent the housing. The base may include surface channels to facilitate moisture transport. Directional and non-directional surface textures are provided. An adhesive patch for securing the on-body device and having a plurality of patch portions is disclosed as is a reinforcement device for reinforcing attachment. The reinforcement device can include a reinforcement leg or a reinforcement band. The adhesive patches can include a non-isotropic layer with an opening and/or a polymeric layer. Adhesive patches with support structures, and variations of support structures, are described. Adhesive patches with various liner configurations are described.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
63.
TRANSCATHETER EDGE-TO-EDGE REPAIR IMPLANT WITH USER-SELECTABLE STIFFNESS
A fixation device includes a primary unit having pair of distal elements and a pair of proximal elements, the pair of distal elements and the pair of proximal elements being configured to retain tissue, a secondary reinforcement coupled to the primary unit and transitionable between a first position spaced away from the primary unit and a second position nested about the primary unit, and a deployment shaft configured to actuate the secondary reinforcement between the first position and the second position. A method of treating a native valve includes providing a fixation device including a primary unit having a pair of distal elements and a pair of proximal elements configured to retain tissue, and a secondary reinforcement, and transitioning the secondary reinforcement from a first position to a second position to increase a stiffness of the fixation device.
A system, method and network architecture for facilitating remote care delivery involving a patient having an implantable medical device (IMD). Upon establishing a remote care session between a patient controller device and a clinician programmer, wherein the clinician and the patient are remotely located with respect to each other, telehealth consultation may be provided to the patient by the clinician via an audiovisual (AV) communications session channel. Responsive to determining that the patient requires remote therapy, one or more (re)programming instructions may be provided to the patient's IMD via a remote therapy session channel of the remote care session using an integrated graphical user interface (GUI) that may include suitable GUI controls for AV communications, remote session control as well as the remote programming of the patient's IMD.
G16H 80/00 - TIC spécialement adaptées pour faciliter la communication entre les professionnels de la santé ou les patients, p. ex. pour le diagnostic collaboratif, la thérapie collaborative ou la surveillance collaborative de l’état de santé
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
H04L 43/04 - Traitement des données de surveillance capturées, p. ex. pour la génération de fichiers journaux
H04L 65/1069 - Établissement ou terminaison d'une session
H04L 65/80 - Dispositions, protocoles ou services dans les réseaux de communication de paquets de données pour prendre en charge les applications en temps réel en répondant à la qualité des services [QoS]
An implantable medical device (IMD) includes a housing, a tip electrode, a plurality of fixation tines, and a deployment mechanism. The housing includes a distal tip. The distal tip has a distal face. The tip electrode is mounted to the distal tip of the housing and is exposed along the distal face. The fixation tines are mounted to the distal tip of the housing. The fixation tines include hook features for securing to tissue of the patient. The deployment mechanism is able to deploy the fixation tines to a deployed state. The fixation tines in the deployed state are exposed along the distal face, and can embed into the tissue of the patient to secure the IMD at a target implant location.
A method and system for managing delivery of a respiration gated defibrillation shock from a subcutaneous implantable medical device (S-IMD) having one or more extra vascular electrodes. The method and system sense cardiac events of a heart. Additionally, the method and system utilize one or more processors to declare a shockable arrhythmia based on the cardiac events, obtain a respiration proxy signal indicative of respiration, track a respiration state related (RSR) characteristic from the respiration proxy signal, gate delivery of a high voltage (HV) shock based on occurrence of a respiration-gated (RG) trigger in connection with the RSR characteristic, and deliver the HV shock along a shocking vector between extra vascular electrodes based on the RG trigger to time delivering of the HV shock to occur during the select state within the respiration cycle.
A method and device for dynamic device based AV delay adjustment are provided. The method provides electrodes that are configured to be located proximate to an atrial (A) site and a right ventricular (RV) site. The method utilizes one or more processors, in an implantable medical device (IMD), for detecting an atrial paced (Ap) event or atrial sensed (As) event. The method determines a measured AV interval corresponding to an interval between the Ap event or the As event and a ventricular sensed event and calculates a percentage-based (PB) offset based on the measured AV interval. The method automatically dynamically adjusting an AV delay, utilized by the IMD, based on the measured AV interval and the PB offset and manages a pacing therapy, utilized by the IMD, based on the AV delay after the adjusting operation.
A61N 1/368 - Stimulateurs cardiaques commandés par un paramètre physiologique, p. ex. par le potentiel cardiaque comprenant plus d'une électrode coopérant avec différentes régions du cœur
A61N 1/365 - Stimulateurs cardiaques commandés par un paramètre physiologique, p. ex. par le potentiel cardiaque
68.
METHOD AND DEVICE FOR CONTROLLING CARDIAC RESYNCHRONIZATION THERAPY BASED ON HEART SOUNDS
A method for controlling an adaptive pacing therapy that includes utilizing one or more processors to perform measuring an atrial – ventricular (AV) interval corresponding to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event, setting an AV delay based on the AV interval, and measuring an S1 heart sound characteristic of interest (COI) while utilizing the AV delay in connection with delivering a pacing therapy by the IMD. The one or more processors also perform adjusting the AV delay, repeating the measuring, and adjusting to obtain a collection of S1 heart sound COIs and corresponding AV delays, selecting one of the AV delays, that corresponds to a select one of the S1 heart sound COIs, as a resultant AV delay, and managing the pacing therapy, utilized by the IMD, based on the resultant AV delay.
A61N 1/368 - Stimulateurs cardiaques commandés par un paramètre physiologique, p. ex. par le potentiel cardiaque comprenant plus d'une électrode coopérant avec différentes régions du cœur
A61N 1/365 - Stimulateurs cardiaques commandés par un paramètre physiologique, p. ex. par le potentiel cardiaque
A catheter assembly is provided. The catheter assembly includes a catheter including at least one lesion generating electrode, the at least one lesion generating electrode configured to be positioned within a patient, and at least one return array configured to be positioned within the patient and remote from the at least one lesion generating electrode, the at least one return array including at least one return electrode, wherein the catheter assembly is configured to apply energy between i) the at least one lesion generating electrode and ii) a return patch and the at least one return electrode to generate lesions proximate the at least one lesion generating electrode.
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
A61B 18/12 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci par chauffage en faisant passer des courants à travers les tissus à chauffer, p. ex. des courants à haute fréquence
A61B 18/16 - Électrodes neutres ou passives pour mise à la terre
70.
ELECTRODE WITH PROTECTED IMPEDANCE REDUCTION COATING
A catheter includes a shaft including a proximal end and a distal end, an electrical conductor coupled to the catheter, and an electrode coupled to the electrical conductor. The electrode includes at least one recessed portion, and an impedance reduction layer disposed in the at least one recessed portion. The impedance reduction layer has a thickness less than a depth of the recessed portion.
A61B 5/287 - Supports pour électrodes multiples, p. ex. cathéters à électrode pour des études électrophysiologiques [EEP]
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
The present disclosure relates to uncleavable anti-Mullerian hormone (AMH) variant polypeptides. The present disclosure also relates to polynucleotides encoding the variants, nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and use of the polypeptides as calibrators in immunoassays with improved assay performance compared to wild type AMH polypeptides.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
72.
ANALYTE MONITORING SYSTEMS WITH ON-BODY DEVICES HAVING IMPROVED WEAR DURATION
An on-body device for monitoring an analyte level of a user has a housing. The housing has a vent inlet and a vent outlet that allow passage of water vapor therethrough. Examples of moisture permeable seals, solid foam seals, and fibrous seals are provided. The housing has a base adapted to permit egress of moisture from regions adjacent the housing. The base may include surface channels to facilitate moisture transport. Directional and non-directional surface textures are provided. An adhesive patch for securing the on-body device and having a plurality of patch portions is disclosed as is a reinforcement device for reinforcing attachment. The reinforcement device can include a reinforcement leg or a reinforcement band. The adhesive patches can include a non-isotropic layer with an opening and/or a polymeric layer. Adhesive patches with support structures, and variations of support structures, are described. Adhesive patches with various liner configurations are described.
Various embodiments of systems, devices and methods for improved meal and therapy interfaces in analyte monitoring systems are disclosed. These embodiments can determine a medication dosage to be administered with the consumption of a meal, identify meal start and meal peak response candidates, and recommend user-initiated analyte checks.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
74.
LENSES HAVING DIFFRACTIVE PROFILES WITH IRREGULAR WIDTH FOR VISION TREATMENT
Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (IOLs), include features for providing improved extended depth of focus lenses. Exemplary ophthalmic lenses can include an optic including a diffractive profile including a plurality of echelettes, each echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile and each echelette of the diffractive profile being configured to distribute light to a distance focus.
B29D 11/00 - Fabrication d'éléments optiques, p. ex. lentilles ou prismes
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
75.
PLATFORM SUPPORTING CENTRALIZED ACCESS FOR REMOTE MRI WORKFLOW FOR IMPLANTED DEVICES
A healthcare system comprises an MR platform comprising non-transitory memory storing program instructions and patient specific records that include information associated with an implantable medical device (IMD) and a patient. The MR platform has processors that, when executing the program instructions, are configured to i) receive an MRI exam referral requesting an MRI exam associated with a first patient specific record from within the patient specific records that has a first IMD and a first patient; ii) responsive to the MRI exam referral, automatically transmit an MRI exam request alert; iii) responsive to receiving a response to the MRI exam request alert, provide access to the first patient specific record; iv) receive MRI settings associated with the first patient specific record that are configured to be programmed into the first IMD in advance of the MRI exam; and v) store the MRI settings in the patient specific record.
G16H 10/65 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients stockées sur des supports d’enregistrement portables, p. ex. des cartes à puce, des étiquettes d’identification radio-fréquence [RFID] ou des CD
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
76.
TRANSCATHETER EDGE-TO-EDGE REPAIR IMPLANT WITH USER-SELECTABLE STIFFNESS
A fixation device includes a primary unit having pair of distal elements and a pair of proximal elements, the pair of distal elements and the pair of proximal elements being configured to retain tissue, a secondary reinforcement coupled to the primary unit and transitionable between a first position spaced away from the primary unit and a second position nested about the primary unit, and a deployment shaft configured to actuate the secondary reinforcement between the first position and the second position. A method of treating a native valve includes providing a fixation device including a primary unit having a pair of distal elements and a pair of proximal elements configured to retain tissue, and a secondary reinforcement, and transitioning the secondary reinforcement from a first position to a second position to increase a stiffness of the fixation device.
Lenses and methods are provided for improving peripheral and/or central vision for patients who suffer from retinal conditions that reduce central vision or patients who have undergone catar-act surgery. The lens has an optic configured to focus light incident along a direction parallel to an optical axis at the fovea to produce a functional foveal image. The optic is configured to focus light incident on the patient's eye at an oblique angle with re-spect to the optical axis at a peripheral retinal location disposed at a distance from the fovea, the peripheral retinal location having an ec-centricity between -30 degrees and 30 de-grees. The image quality at the peripheral retinal location is improved by reducing at least one optical aberration at the peripheral retinal location. The method for improving vision utilizes ocular measurements to iteratively ad-just the shape factor of the lens to reduce peri-pheral refractive errors.
A61B 3/10 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient
A medical device includes a polymer scaffold crimped to a catheter having an expansion balloon. The scaffold, after being deployed by the balloon, provides a crush recovery of about 90% after the diameter of the scaffold has been pinched or crushed by 50%. The scaffold has a pattern including an asymmetric closed cell connecting links connecting the closed cells.
A61F 2/915 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles caractérisés par une structure de type filet ou de type à mailles fabriquée à partir de feuilles perforées ou de tubes perforés, p. ex. perforés par découpe au laser ou gravés avec des bandes présentant une structure en méandre, des bandes adjacentes étant reliées l’une à l’autre
A61F 2/82 - Dispositifs maintenant le passage ou évitant l’affaissement de structures tubulaires du corps, p. ex. stents
A61F 2/844 - Dispositifs maintenant le passage ou évitant l’affaissement de structures tubulaires du corps, p. ex. stents repliés avant déploiement
A61F 2/86 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles
A61F 2/89 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles les éléments filiformes comprenant au moins deux anneaux adjacents reliés de manière flexible par des éléments séparés
A61F 2/91 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles caractérisés par une structure de type filet ou de type à mailles fabriquée à partir de feuilles perforées ou de tubes perforés, p. ex. perforés par découpe au laser ou gravés
A61F 2/95 - Instruments spécialement adaptés pour insérer ou retirer les stents ou les endoprothèses déployables couvertes
A61F 2/958 - Instruments spécialement adaptés pour insérer ou retirer les stents ou les endoprothèses déployables couvertes ballons gonflables pour insérer les stents ou les endoprothèses déployables couvertes
A61L 27/00 - Matériaux pour prothèses ou pour revêtement de prothèses
A61L 31/06 - Matériaux macromoléculaires obtenus autrement que par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone
A61L 31/14 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques
B21D 39/04 - Utilisation de procédés permettant d'assembler des objets ou des parties d'objets, p. ex. revêtement par des tôles, autrement que par placageDispositifs de mandrinage des tubes des tubes avec des tubesUtilisation de procédés permettant d'assembler des objets ou des parties d'objets, p. ex. revêtement par des tôles, autrement que par placageDispositifs de mandrinage des tubes des tubes avec des barres
B29C 35/08 - Chauffage ou durcissement, p. ex. réticulation ou vulcanisation utilisant l'énergie ondulatoire ou un rayonnement corpusculaire
B29K 67/00 - Utilisation de polyesters comme matière de moulage
Devices and methods for removing a valve clip which is pre-positioned on a heart leaflet, the valve clip including a delivery catheter having a distal end portion configured to be positioned near a heart valve; a grasping tool deployable from the distal end portion of the delivery catheter, the grasping tool configured to grasp and manipulate a valve clip from an implanted condition to an elongated condition, wherein the valve clip in the elongated condition has an elongated width less than an implanted width of the valve clip in the implanted condition; and a removal tool extendable relative to the distal end portion of the delivery catheter, the removal tool configured to at least partially surround the valve clip in the elongated condition and to remove the valve clip from the heart valve leaflet.
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
A61B 18/24 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci par application de radiations électromagnétiques, p. ex. de micro-ondes en utilisant des lasers le faisceau étant dirigé le long, ou à l'intérieur d'un conduit flexible, p. ex. d'une fibre optiquePièces à main à cet effet avec un cathéter
81.
SYSTEMS AND METHODS FOR DETECTING EVOKED COMPOUND ACTION POTENTIAL (ECAP) AND/OR STIMULATION ARTIFACT FEATURES IN RESPONSE TO NEUROSTIMULATION
Systems and methods are disclosed for conducting spinal cord stimulation or other neurostimulation and sensing evoked compound action potential (ECAP) signals. The sensed signals may be processed to isolate ECAP features from noise and/or interfering signals. The isolated ECAP features may be used to control neurostimulation therapy for the patient, such as to quantify or measure lead migration and adjust a neurostimulation therapy for the patient to account for an impact of any detected lead migration, or other purposes (e.g., to guide an implant procedure).
A61B 5/388 - Études de la conduction nerveuse, p. ex. détection du potentiel d’action d’un nerf périphérique
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
82.
SYSTEMS, APPARATUSES, AND METHODS FOR ALIGNMENT OF DEVICE FOR CORNEA AND/OR SCLERA TREATMENT
Apparatus, systems, and methods for aligning a device on an eye, particularly centering a UV device with respect to a center of a visual axis of an eye or a center of a pupil. An alignment feature may be used to align a support body to a desired location of the eye. The support body may be used in conjunction with a variety of UV treatment devices for eyes.
A scaffold includes a radiopaque marker connected to a strut. The marker is retained within the strut by a head at one or both ends. The marker is attached to the strut by a process that includes forming a rivet from a radiopaque bead and attaching the rivet to the marker including deforming the rivet to enhance resistance to dislodgement during crimping or balloon expansion. The strut has a thickness of about 100 microns.
A61F 2/915 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles caractérisés par une structure de type filet ou de type à mailles fabriquée à partir de feuilles perforées ou de tubes perforés, p. ex. perforés par découpe au laser ou gravés avec des bandes présentant une structure en méandre, des bandes adjacentes étant reliées l’une à l’autre
A61F 2/844 - Dispositifs maintenant le passage ou évitant l’affaissement de structures tubulaires du corps, p. ex. stents repliés avant déploiement
A61F 2/86 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles
A61F 2/89 - Stents ayant une forme caractérisée par des éléments filiformesStents ayant une forme caractérisée par une structure de type filet ou de type à mailles les éléments filiformes comprenant au moins deux anneaux adjacents reliés de manière flexible par des éléments séparés
The present disclosure provides analyte sensors including one or more NAD(P)-dependent enzymes and an internal supply of NAD(P) for the detection of an analyte. The present disclosure further provides methods of using such analyte sensors for detecting one or more analytes present in a biological sample of a subject, and methods of manufacturing said analyte sensors.
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
C12Q 1/32 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir une oxydoréductase une déshydrogénase
The capacitor has an electrode stack with faces between one or more edges. A bent portion of the one or more edges has a bend in the one or more edges. An adhesive film is positioned on the electrode stack such that an edge region of the adhesive film is over the bent portion of the one or more edges. The adhesive film includes multiple flaps. The multiple flaps include a first flap connected to a first portion of the edge region and a second flap connected to a second portion of the edge region. The first flap and the second flap are positioned over a first one of the faces of the electrode stack. A lateral edge of the first flap intersects a lateral edge of the second flap at a common location.
H01G 9/042 - Électrodes caractérisées par le matériau
H01G 9/00 - Condensateurs électrolytiques, redresseurs électrolytiques, détecteurs électrolytiques, dispositifs de commutation électrolytiques, dispositifs électrolytiques photosensibles ou sensibles à la températureProcédés pour leur fabrication
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations, medicines for human use;
sanitary preparations for medical use; dietetic food and
substances adapted for medical use; nutraceutical
preparations for therapeutic or medical use; dietary
supplements; vitamin preparations; plasters, material for
dressings.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations, medicines for human use;
sanitary preparations for medical use; dietetic food and
substances adapted for medical use; nutraceutical
preparations for therapeutic or medical use; dietary
supplements; vitamin preparations; plasters, material for
dressings.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations, medicines for human purposes;
sanitary preparations for medical purposes; dietetic food
and substances adapted for medical use; nutraceutical
preparations for therapeutic or medical purposes; dietary
supplements; vitamin preparations; plasters, materials for
dressings.
A sensor tail includes a carbon-based electrode material that, as a result of being at least partially inserted into tissue, interacts with interstitial fluid to generate a signal that is proportional to a concentration of a physiological condition. The sensor tail includes an isolation membrane that overcoats at least a portion of the carbon-based electrode material. The sensor tail includes an immuno-suppressive membrane that operates to control an immune response of the user's body. A portion of the isolation membrane is subjected to a welting process that causes the isolation membrane to swell, thereby forming a swelled portion that rises above non-swelled portions of the isolation membrane. The swelled portion is shaped to form a cavity. The immuno-suppressive membrane is deposited in the cavity.
A computer implemented method and system is provided for managing neural stimulation therapy. The method comprises under control of one or more processors configured with program instructions. The method delivers a series of candidate stimulation waveforms having varied stimulation intensities to at least one electrode located proximate to nervous tissue of interest. A parameter defines the candidate stimulation waveforms is changed to vary the stimulation intensity. The method identifies a first candidate stimulation waveform that induces a paresthesia-abatement effect, while continuing to induce a select analgesic effect. The method further identifies a second candidate stimulation waveform that does not induce the select analgesic effect. The method sets a stimulation therapy based on the first and second candidate stimulation waveforms.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/24 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A medical device can comprise a catheter shaft comprising a proximal end and a distal end, the catheter shaft defining a catheter shaft longitudinal axis. A flexible tip portion can be located adjacent to the distal end of the catheter shaft, the flexible tip portion comprising a flexible framework. A plurality of curved microelectrodes can be disposed on the flexible framework and can form a flexible array of curved microelectrodes adapted to conform to tissue.
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci
96.
OPTICALLY CONDITIONED TISSUE IMAGING FOR ELECTROCHEMICAL SENSOR SKEW CORRECTION
A sensor measures a physiological condition (e.g., glucose) of a user. The sensor also facilitates an assessment of a transient sensor signal skew that occurs to the sensor's signal. The transient sensor signal skew occurs as a result of an immune response or bleeding from the user's body, where the immune response or bleeding occurs in response to an insertion and/or subsequent retained presence of the sensor tail in the user's body. The sensor includes an optical sensor. As a result of an ointment being applied to a top layer of the user's skin, the skin becomes at least partially translucent. The optical sensor is directed towards the top layer of the skin onto which the ointment was applied. The optical sensor is structured to generate images of the translucent skin. The images reflect inflammation occurring under the skin. The transient sensor skew is based on the detected inflammation.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1459 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
G01N 33/49 - Analyse physique de matériau biologique de matériau biologique liquide de sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
H04W 4/38 - Services spécialement adaptés à des environnements, à des situations ou à des fins spécifiques pour la collecte d’informations de capteurs
H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie
H04W 12/02 - Protection de la confidentialité ou de l'anonymat, p. ex. protection des informations personnellement identifiables [PII]
A system for verifying a candidate pathologic episode of a patient is provided that includes an accelerometer configured to be implanted in the patient. The accelerometer is configured to obtain accelerometer data along at least one axis. The system also includes a memory configured to store program instructions, and one or more processors that, when executing the program instructions, are configured to obtain accelerometer data. The one or more processors are also configured to determine a plurality of control three-dimensional point vectors related to the accelerometer data, and obtain a biological signal and identify a candidate pathologic episode based on the biological signal. The one or more processors are also configured to analyze the plurality of control three-dimensional point vectors to identify a physical action experienced by the patient, and verify the candidate pathologic episode based on the physical action.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
G01P 15/18 - Mesure de l'accélérationMesure de la décélérationMesure des chocs, c.-à-d. d'une variation brusque de l'accélération dans plusieurs dimensions
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations, medicines for human use;
sanitary preparations for medical use; dietetic food and
substances adapted for medical use; nutraceutical
preparations for therapeutic or medical use; dietary
supplements; vitamin preparations; plasters, materials for
dressings.
